Novartis Investigative Site

Berkeley, California 94705

We've found

1 trials

at this facility

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Berkeley, CA

Use our guide to learn which trials are right for you!